Stocks making the biggest moves midday: Merck, Bristol-Myers Squibb, Align Technology and more

ایران اخبار اخبار

Stocks making the biggest moves midday: Merck, Bristol-Myers Squibb, Align Technology and more
ایران آخرین اخبار,ایران سرفصلها

These are the stocks posting the largest moves in midday trading.

  • 📰 CNBC
  • ⏱ Reading Time:
  • 24 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 72%

Check out the companies making headlines in midday trading. Bunge — Shares of the global crop trader and processor popped 5.2% after the company lifted its 2023 outlook and reported better-than-expected profit for the third quarter. Bunge's earnings were lower year-on-year, however. Comcast — Comcast shares fell 6.3% after the telecom giant reported a loss in high-speed broadband subscribers. Advertising revenue from NBCUniversal was also weak.

Align Technology — The medical device maker dropped 25% on Thursday after missing Wall Street forecasts in the third quarter and offering weak guidance for current-quarter revenue. Align posted $2.14 in earnings per share excluding items and $960 million in revenue in the third quarter. Analysts polled by LSEG expected earnings of $2.26 per share and revenue at $995 million. American Tower Corporation — The American real estate investment trust added 8.

این خبر را خلاصه کرده ایم تا بتوانید سریع آن را بخوانید. اگر به خبر علاقه مند هستید، می توانید متن کامل را اینجا بخوانید. ادامه مطلب:

CNBC /  🏆 12. in İR
 

ایران آخرین اخبار, ایران سرفصلها

Similar News:همچنین می توانید اخبار مشابهی را که از منابع خبری دیگر جمع آوری کرده ایم، بخوانید.

Bristol-Myers Squibb earnings top estimatesBristol-Myers Squibb earnings top estimatesCiara Linnane is MarketWatch's investing- and corporate-news editor. She is based in New York.
ادامه مطلب »

Bristol Myers Squibb earnings top estimates even as top-selling drug fights generic competitionBristol Myers Squibb earnings top estimates even as top-selling drug fights generic competitionBristol Myers Squibb’s revenue was in line with estimates, but fell slightly from the same period last year due to lower sales of blood cancer drug Revlimid.
ادامه مطلب »

Japanese stocks rise for second session as Hong Kong stocks gainJapanese stocks rise for second session as Hong Kong stocks gainSupported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with unparalleled accuracy.
ادامه مطلب »



Render Time: 2025-01-20 00:09:30